UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

State of the art and future directions of pancreatic ductal adenocarcinoma therapy

Pharmacology & therapeutics (Oxford), 2015-11, Vol.155, p.80-104

2015

Volltextzugriff (PDF)

Gene Therapy in a Patient with Sickle Cell Disease

The New England journal of medicine, 2017-03, Vol.376 (9), p.848-855

2017

Volltextzugriff (PDF)

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

The New England journal of medicine, 2018-04, Vol.378 (16), p.1479-1493

2018

Volltextzugriff (PDF)

Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems

Journal of pain and symptom management, 2010-07, Vol.40 (1), p.87-94

2010

Volltextzugriff (PDF)

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene

Human gene therapy, 2016-02, Vol.27 (2), p.148

2016

Volltextzugriff (PDF)

New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity

The Journal of pharmacology and experimental therapeutics, 2009-02, Vol.328 (2), p.598

2009

Volltextzugriff (PDF)

Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial

Nature medicine, 2022-01, Vol.28 (1), p.81-88

2022

Volltextzugriff (PDF)

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial

Lancet neurology, 2017-09, Vol.16 (9), p.712-720

2017

Volltextzugriff (PDF)

Routine application of Raman spectroscopy in the quality control of hospital compounded ganciclovir

International journal of pharmaceutics, 2014-10, Vol.474 (1-2), p.193-201

2014

Volltextzugriff (PDF)

Design and Development of a User-Friendly Motorized Apparatus for the Filling of Portable Infusion Pumps by Hospital and Homecare Health Workers

Pharmaceutical technology in hospital pharmacy, 2016-03, Vol.1 (1), p.21-28

2016

Volltextzugriff (PDF)

Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas

Pharmacology & therapeutics (Oxford), 2017-06, Vol.174, p.145-172

2017

Volltextzugriff (PDF)

Comparison of Raman spectroscopy vs. high performance liquid chromatography for quality control of complex therapeutic objects: Model of elastomeric portable pumps filled with a fluorouracil solution

Journal of pharmaceutical and biomedical analysis, 2014-03, Vol.91, p.176-184

2014

Volltextzugriff (PDF)

The contribution of Raman spectroscopy to the analytical quality control of cytotoxic drugs in a hospital environment: Eliminating the exposure risks for staff members and their work environment

International journal of pharmaceutics, 2014-08, Vol.470 (1-2), p.70-76

2014

Volltextzugriff (PDF)

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network

Bone marrow transplantation (Basingstoke), 2022-06, Vol.57 (6), p.966-974

2022

Volltextzugriff (PDF)

Liquid chromatography-mass spectrometry assay for quantitation of ifosfamide and its N-deschloroethylated metabolites in rat microsomal medium

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-06, Vol.820 (2), p.251-259

2005

Volltextzugriff (PDF)

Midostaurin in Advanced Systemic Mastocytosis

The New England journal of medicine, 2016-06, Vol.374 (26), p.2605-2606

2016

Volltextzugriff (PDF)

Contribution and limits of a non-intrusive Raman spectroscopic method compared with HPLC for routine application to pre-delivery analytical control of two major camptothecin analogs: irinotecan and topotecan

Journal of Raman spectroscopy, 2015-12, Vol.46 (12), p.1283-1290

2015

Volltextzugriff (PDF)

New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning

Pediatric blood & cancer, 2020-10, Vol.67 (10), p.e28603-n/a

2020

Volltextzugriff (PDF)

Abstract B57: Effects of MEK inhibition alone or in combination with PI3K-mTOR pathway inhibitors in pancreatic ductal adenocarcinoma in vitro and on an innovative ex vivo fresh tumor tissue culture model

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (24_Supplement), p.B57-B57

2016

Volltextzugriff (PDF)

Models for placental transfer studies of drugs

Clinical pharmacokinetics, 1995-02, Vol.28 (2), p.161-180

1995

Volltextzugriff (PDF)

Abstract 2677: Decrease in phospho-S6 expression under MEK inhibitor (MEKi) treatment as a potential predictive biomarker of response to MEKi alone or in combination with PI3K-mTOR pathway inhibitor in pancreatic adenocarcinoma in vitro and ex vivo models

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2677-2677

2015

Volltextzugriff (PDF)

Gene Therapy in Patients with Transfusion-Dependent ?-Thalassemia

The New England journal of medicine, 2018-04, Vol.378 (16), p.1479

2018

Volltextzugriff (PDF)

Correlation of decreased pS6 expression under MEK inhibitor (MEKi) with response to MEKi alone or combined with PI3K-mTOR inhibitor (PI3Ki-mTORi) in pancreatic adenocarcinoma (PAC) in vitro and ex vivo models

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15262-e15262

2015

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(113)
Bücher
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(62)
Humans
(42)
Biological And Medical Sciences
(30)
Medical Sciences
(22)
Pharmacology. Drug Treatments
(21)
Female
(18)
Pharmacology & Pharmacy
(17)
Physical Sciences
(16)
Adult
(15)
Animals
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Male
(11)
Quality Control
(11)
Pregnancy
(10)
Chemistry
(8)
Drug Stability
(8)
Life Sciences
(8)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(7)
Busulfan
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

State of the art and future directions of pancreatic ductal adenocarcinoma therapy

Gene Therapy in a Patient with Sickle Cell Disease

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene

New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity

Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial

Routine application of Raman spectroscopy in the quality control of hospital compounded ganciclovir

Design and Development of a User-Friendly Motorized Apparatus for the Filling of Portable Infusion Pumps by Hospital and Homecare Health Workers

Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas

Comparison of Raman spectroscopy vs. high performance liquid chromatography for quality control of complex therapeutic objects: Model of elastomeric portable pumps filled with a fluorouracil solution

The contribution of Raman spectroscopy to the analytical quality control of cytotoxic drugs in a hospital environment: Eliminating the exposure risks for staff members and their work environment

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network

Liquid chromatography-mass spectrometry assay for quantitation of ifosfamide and its N-deschloroethylated metabolites in rat microsomal medium

Midostaurin in Advanced Systemic Mastocytosis

Contribution and limits of a non-intrusive Raman spectroscopic method compared with HPLC for routine application to pre-delivery analytical control of two major camptothecin analogs: irinotecan and topotecan

New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning

Abstract B57: Effects of MEK inhibition alone or in combination with PI3K-mTOR pathway inhibitors in pancreatic ductal adenocarcinoma in vitro and on an innovative ex vivo fresh tumor tissue culture model

Models for placental transfer studies of drugs

Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy

Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy

Abstract 2677: Decrease in phospho-S6 expression under MEK inhibitor (MEKi) treatment as a potential predictive biomarker of response to MEKi alone or in combination with PI3K-mTOR pathway inhibitor in pancreatic adenocarcinoma in vitro and ex vivo models

Gene Therapy in Patients with Transfusion-Dependent ?-Thalassemia

Correlation of decreased pS6 expression under MEK inhibitor (MEKi) with response to MEKi alone or combined with PI3K-mTOR inhibitor (PI3Ki-mTORi) in pancreatic adenocarcinoma (PAC) in vitro and ex vivo models

Suchergebnisse filtern